期刊
MOLECULAR NEUROBIOLOGY
卷 46, 期 3, 页码 605-613出版社
SPRINGER
DOI: 10.1007/s12035-012-8313-6
关键词
beta-Amyloid; Insulin; Insulin-like growth factor 1; Alzheimer's disease
资金
- Italian Ministry of University and Research
Alzheimer's disease is the most common form of dementia among older people and is still untreatable. While beta-amyloid protein is recognized as the disease determinant with a pivotal role in inducing neuronal loss and dementia, an impaired brain insulin signaling seems to account in part for the cognitive deficit associated with the disease. The origin of this defective signaling is uncertain. Accumulating toxic species of beta-amyloid, the so-called oligomers, has been proposed to be responsible for downregulation of neuronal insulin receptors. We have found that the nontoxic form of beta-amyloid, the monomer, is able to activate insulin/insulin-like growth factor-1 (IGF-1) receptor signaling and thus behaves as a neuroprotectant agent. Our suggestion is that depletion of beta-amyloid monomers, occurring in the preclinical phase of Alzheimer's disease, might be the cause of early insulin/IGF-1 signaling disturbances that anticipate cognitive decline.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据